8-K Announcements
6Material company update
Jan 20, 2026·SEC
Material company update
Dec 16, 2025·SEC
Material company update
Nov 26, 2025·SEC
Synlogic, Inc.(SYBX)Earnings, Financials & Key Ratios
SYBX•NASDAQ
Price updated Jun 19, 2026
AboutSynlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd; Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.Show more
- Revenue$0-100.0%
- EBITDA-$4M+91.1%
- Net Income-$1M+95.7%
- EPS (Diluted)-0.08+95.8%
- ROE-8.17%+90.3%
SYBX Key Insights
Synlogic, Inc. (SYBX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 55.7%
- ✓High quality earnings: Operating CF exceeds net income
- ✓Trading at only 0.7x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SYBX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SYBX Price & Volume
Synlogic, Inc. (SYBX) stock price & volume — 10-year historical chart
Loading chart...
SYBX Growth Metrics
Synlogic, Inc. (SYBX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-125%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-145.6%
Return on Capital
10 Years-52.59%
5 Years-63.31%
3 Years-74.96%
Last Year-32.57%
SYBX Peer Comparison
Synlogic, Inc. (SYBX) competitors in Microbiome and Phage Therapeutics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 IMVT | 7.26B | 35.34 | -12.76 | -68.16% | 0.00 | |||
 ACMR | 7.28B | 109.87 | 80.20 | 15.24% | 9.48% | 5.13% | 0.16 | |
 AGEN | 124.93M | 3.00 | -882.35 | 10.37% | 52.16% | |||
 NKTR | 1.19B | 60.98 | -6.27 | -43.89% | -284.18% | -87% | 1.66 | |
 MIRM | 5.38B | 107.13 | -227.94 | 54.74% | -194.97% | -289.33% | 1.02 | |
 ARWR | 11.52B | 81.82 | -6706.56 | 232.58% | -48.38% | -55.09% | 0.73 | |
 RCKT | 365.8M | 3.35 | -1.67 | -70.79% | 0.09 | |||
 ILMN | 24.6B | 161.93 | 29.71 | -0.78% | 19.43% | 32.84% | 0.94 |
Compare SYBX vs Peers
Synlogic, Inc. (SYBX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SYBX Income Statement
Synlogic, Inc. (SYBX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 2.44M | 2.52M | 2.22M | 545K | 1.75M | 1.18M | 3.37M | 8K | 0 | 0 |
Revenue Growth % | 450.45% | 3.11% | -11.75% | -75.49% | 221.83% | -32.73% | 185.68% | -99.76% | -100% | - |
Cost of Goods Sold | 0 | 14.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COGS % of Revenue | - | 591.15% | - | - | - | - | - | - | - | - |
Gross Profit | 2.44M▲ 0% | -12.38M▼ 606.4% | 2.22M▲ 118.0% | 545K▼ 75.5% | 1.75M▲ 221.8% | 1.18M▼ 32.7% | 3.37M▲ 185.7% | 8K▼ 99.8% | 0▼ 100.0% | 0▲ 0% |
Gross Margin % | 100% | -491.15% | 100% | 100% | 100% | 100% | 100% | 100% | - | - |
Gross Profit Growth % | 757.54% | -606.42% | 117.97% | -75.49% | 221.83% | -32.73% | 185.68% | -99.76% | -100% | - |
Operating Expenses | 43.27M | 53.75M | 56.63M | 61.01M | 62.52M | 68.6M | 58.53M | 40.96M | 4.01M | 4.63M |
OpEx % of Revenue | 1770.38% | 2132.94% | 2546.45% | 11194.68% | 3564.37% | 5813.47% | 1736.34% | 511975% | - | - |
Selling, General & Admin | 12.93M | 15.72M | 14.73M | 13.54M | 15.39M | 16.55M | 14.56M | 6.63M | 3.49M | 3.72M |
SG&A % of Revenue | 528.93% | 623.65% | 662.23% | 2483.85% | 877.54% | 1402.97% | 431.95% | 82887.5% | - | - |
Research & Development | 30.34M | 38.03M | 41.91M | 47.47M | 47.13M | 52.04M | 43.97M | 9.15M | 43K | 70K |
R&D % of Revenue | 1241.45% | 1509.29% | 1884.22% | 8710.83% | 2686.83% | 4410.51% | 1304.39% | 114425% | - | - |
Other Operating Expenses | 0 | 2.79M | 0 | 0 | 0 | 0 | 0 | 25.17M | 476K | 838K |
Operating Income | -40.82M▲ 0% | -51.23M▼ 25.5% | -54.41M▼ 6.2% | -60.47M▼ 11.1% | -60.77M▼ 0.5% | -67.42M▼ 11.0% | -55.16M▲ 18.2% | -40.95M▲ 25.8% | -4.01M▲ 90.2% | -4.63M▲ 0% |
Operating Margin % | -1670.38% | -2032.94% | -2446.45% | -11094.68% | -3464.37% | -5713.47% | -1636.34% | -511875% | - | - |
Operating Income Growth % | -53.37% | -25.49% | -6.21% | -11.13% | -0.49% | -10.95% | 18.18% | 25.76% | 90.21% | - |
EBITDA | -38.51M | -48.81M | -51.71M | -57.83M | -58.32M | -64.9M | -53.2M | -39.66M | -3.53M | -3.74M |
EBITDA Margin % | -1575.86% | -1936.87% | -2324.95% | -10611.01% | -3325.09% | -5499.92% | -1578.26% | -495687.5% | - | - |
EBITDA Growth % | -48.55% | -26.73% | -5.94% | -11.84% | -0.85% | -11.28% | 18.02% | 25.46% | 91.09% | -368.58% |
D&A (Non-Cash Add-back) | 2.31M | 2.42M | 2.7M | 2.64M | 2.44M | 2.52M | 1.96M | 1.29M | 0 | 0 |
EBIT | -40.32M | -48.39M | -51.35M | -59.17M | -60.56M | -66.14M | -57.27M | -23.35M | -3.53M | -3.74M |
Net Interest Income | 447K | 2.8M | 3.04M | 1.3M | 208K | 1.26M | 2.47M | 1.43M | 695K | 635K |
Interest Income | 504K | 2.84M | 3.06M | 1.3M | 210K | 1.27M | 2.47M | 1.43M | 695K | 635K |
Interest Expense | 57K | 43K | 21K | 6K | 2K | 2K | 1K | 0 | 0 | 0 |
Other Income/Expense | 447K | 2.79M | 3.04M | 1.29M | 204K | 1.27M | -2.11M | 17.6M | 3M | 3.98M |
Pretax Income | -40.38M▲ 0% | -48.44M▼ 20.0% | -51.37M▼ 6.1% | -59.17M▼ 15.2% | -60.56M▼ 2.3% | -66.15M▼ 9.2% | -57.27M▲ 13.4% | -23.35M▲ 59.2% | -1M▲ 95.7% | -641K▲ 0% |
Pretax Margin % | -1652.09% | -1922.02% | -2309.94% | -10857.43% | -3452.74% | -5605.68% | -1698.84% | -291925% | - | - |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 14K | 5K | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | -0.02% | -0.02% | 0% | 0% |
Net Income | -40.38M▲ 0% | -48.44M▼ 20.0% | -51.37M▼ 6.1% | -59.17M▼ 15.2% | -60.56M▼ 2.3% | -66.15M▼ 9.2% | -57.28M▲ 13.4% | -23.36M▲ 59.2% | -1M▲ 95.7% | -641K▲ 0% |
Net Margin % | -1652.09% | -1922.02% | -2309.94% | -10857.43% | -3452.74% | -5605.68% | -1699.26% | -291987.5% | - | - |
Net Income Growth % | -53.71% | -19.96% | -6.07% | -15.18% | -2.35% | -9.22% | 13.4% | 59.22% | 95.7% | -125% |
Net Income (Continuing) | -40.38M | -48.44M | -51.37M | -59.17M | -60.56M | -66.15M | -57.28M | -23.36M | -1M | -641K |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -90.07▲ 0% | -30.42▲ 66.2% | -24.11▲ 20.7% | -23.67▲ 1.8% | -15.76▲ 33.4% | -13.57▲ 13.9% | -8.81▲ 35.1% | -1.92▲ 78.2% | -0.08▲ 95.8% | -0.05▲ 0% |
EPS Growth % | -920.05% | 66.23% | 20.74% | 1.82% | 33.42% | 13.9% | 35.08% | 78.21% | 95.83% | -145.6% |
EPS (Basic) | -90.07 | -30.42 | -24.11 | -23.67 | -15.76 | -13.57 | -8.81 | -1.92 | -0.08 | - |
Diluted Shares Outstanding | 448.31K | 1.59M | 2.02M | 2.39M | 3.69M | 4.78M | 6.5M | 12.2M | 12.31M | 12.4M |
Basic Shares Outstanding | 448.31K | 1.59M | 2.02M | 2.39M | 3.69M | 4.78M | 6.5M | 12.2M | 12.31M | 12.39M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
SYBX Balance Sheet
Synlogic, Inc. (SYBX) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 87.03M | 122.73M | 133.25M | 106.85M | 133.31M | 79.78M | 49.91M | 19.78M | 15.4M | 14.56M |
Cash & Short-Term Investments | 87.03M | 122.73M | 119.57M | 100.44M | 128.59M | 77.63M | 47.75M | 18.86M | 14.67M | 14.11M |
Cash Only | 87.03M | 11.25M | 26.18M | 32.51M | 16.44M | 15.86M | 23.96M | 18.86M | 14.67M | 14.11M |
Short-Term Investments | 0 | 111.48M | 93.39M | 67.94M | 112.15M | 61.77M | 23.79M | 0 | 0 | 0 |
Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
Other Current Assets | 298K | 388K | 648K | 247K | 311K | 175K | 146K | 161K | 729K | 456K |
Total Non-Current Assets | 12.67M | 17.61M | 55.33M | 36.99M | 41.43M | 31.08M | 25.64M | 50K | 50K | 50K |
Property, Plant & Equipment | 9.78M | 14.84M | 30.28M | 26.3M | 22.98M | 21.68M | 17.7M | 0 | 0 | 0 |
Fixed Asset Turnover | 0.25x | 0.17x | 0.07x | 0.02x | 0.08x | 0.05x | 0.19x | - | - | - |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 16.38M | 9.59M | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 1.1M | 1.1M | 7.5M | 0 | 9.14M | 1.1M | 0 | 50K | 0 | 50K |
Other Non-Current Assets | 1.79M | 1.67M | 1.16M | 1.1M | 9.31M | 8.31M | 7.94M | 0 | 50K | 50K |
Total Assets | 99.7M▲ 0% | 140.34M▲ 40.8% | 188.57M▲ 34.4% | 143.84M▼ 23.7% | 174.74M▲ 21.5% | 110.86M▼ 36.6% | 75.55M▼ 31.9% | 19.83M▼ 73.8% | 15.45M▼ 22.1% | 14.61M▲ 0% |
Asset Turnover | 0.02x | 0.02x | 0.01x | 0.00x | 0.01x | 0.01x | 0.04x | 0.00x | - | 0.00x |
Asset Growth % | 55.38% | 40.76% | 34.37% | -23.72% | 21.48% | -36.55% | -31.85% | -73.76% | -22.09% | -80.71% |
Total Current Liabilities | 9.03M | 8.34M | 8.86M | 8.3M | 10.08M | 12.12M | 20.4M | 7.08M | 3.58M | 2.06M |
Accounts Payable | 2.68M | 2.38M | 2.17M | 2M | 1.94M | 1.78M | 1.46M | 164K | 103K | 206K |
Days Payables Outstanding | - | 58.31 | - | - | - | - | - | - | - | - |
Short-Term Debt | 0 | 0 | 0 | 0 | 3.2M | 4.17M | 0 | 0 | 0 | 0 |
Deferred Revenue (Current) | 444K | 268K | 544K | 0 | 531K | 882K | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3.76M | 393K | 0 | 0 | 907K | 1.89M | 11.61M | 6.91M | 3.48M | 1.85M |
Current Ratio | 9.64x | 14.71x | 15.03x | 12.87x | 13.23x | 6.58x | 2.45x | 2.80x | 4.30x | 7.08x |
Quick Ratio | 9.64x | 14.71x | 15.03x | 12.87x | 13.23x | 6.58x | 2.45x | 2.80x | 4.30x | 7.08x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 5.63M | 7.9M | 22.81M | 20.4M | 17.39M | 16.13M | 12.49M | 0 | 0 | 0 |
Long-Term Debt | 466K | 210K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 466K | 210K | 22.81M | 20.27M | 17.39M | 16.13M | 12.49M | 0 | 0 | 0 |
Deferred Tax Liabilities | -466K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4.03M | 7.48M | 0 | 131K | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 14.66M | 16.24M | 31.67M | 28.7M | 27.47M | 28.25M | 32.9M | 7.08M | 3.58M | 2.06M |
Total Debt | 891K | 476K | 25.01M | 22.81M | 20.59M | 20.3M | 17.27M | 0 | 0 | 0 |
Net Debt | -86.13M | -10.78M | -1.17M | -9.7M | 4.16M | 4.44M | -6.68M | -18.86M | -14.67M | -14.11M |
Debt / Equity | 0.01x | 0.00x | 0.16x | 0.20x | 0.14x | 0.25x | 0.40x | - | - | 0.00x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.00x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 3.77x |
Interest Coverage | -707.37x | -1125.40x | -2445.33x | -9861.17x | -30279.50x | -33072.50x | -57267.00x | - | - | - |
Total Equity | 85.04M▲ 0% | 124.1M▲ 45.9% | 156.91M▲ 26.4% | 115.14M▼ 26.6% | 147.27M▲ 27.9% | 82.61M▼ 43.9% | 42.66M▼ 48.4% | 12.75M▼ 70.1% | 11.86M▼ 7.0% | 12.55M▲ 0% |
Equity Growth % | 40.9% | 45.93% | 26.44% | -26.62% | 27.91% | -43.9% | -48.37% | -70.11% | -6.96% | -53.52% |
Book Value per Share | 189.69 | 77.94 | 77.72 | 48.19 | 39.92 | 17.28 | 6.56 | 1.05 | 0.96 | 1.01 |
Total Shareholders' Equity | 85.04M | 124.1M | 156.91M | 115.14M | 147.27M | 82.61M | 42.66M | 12.75M | 11.86M | 12.55M |
Common Stock | 16K | 25K | 33K | 38K | 70K | 71K | 10K | 12K | 12K | 12K |
Retained Earnings | -71.65M | -119.77M | -171.14M | -230.31M | -290.87M | -357.02M | -414.3M | -441.65M | -442.66M | -441.98M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | -2.52M | -2.52M | -2.52M | -2.52M | -2.52M |
Accumulated OCI | -9K | -65K | 110K | 14K | -45K | -161K | 6K | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SYBX Cash Flow Statement
Synlogic, Inc. (SYBX) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -31.05M | -42.47M | -75.47M | -39.55M | -52.2M | -56.89M | -51.61M | -31.66M | -4.36M | -3.32M |
Operating CF Margin % | -1270.66% | -1685.32% | -3393.35% | -7257.43% | -2975.94% | -4821.02% | -1531.12% | -395725% | - | - |
Operating CF Growth % | -25.2% | -36.76% | -77.7% | 47.59% | -31.97% | -8.98% | 9.27% | 38.66% | 86.23% | -21.93% |
Net Income | -40.38M | -48.44M | -51.37M | -59.17M | -60.56M | -66.15M | -61.27M | -23.36M | -1M | -641K |
Depreciation & Amortization | 2.31M | 2.42M | 2.7M | 2.64M | 2.44M | 2.52M | 1.96M | 347K | 0 | 0 |
Stock-Based Compensation | 2.65M | 4.32M | 4.13M | 3.91M | 3.36M | 3.64M | 2.81M | 3.17M | 117K | 102K |
Deferred Taxes | -1K | 0 | 0 | -21K | 261K | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 1.75M | -1.39M | 88K | 1.74M | 2.1M | 2.38M | 11.06M | -97K | -2.39M | -2.63M |
Working Capital Changes | 2.61M | 620K | -31.02M | 11.36M | 200K | 723K | -6.17M | -11.72M | -1.08M | -149K |
Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 4.07M | -257K | 0 | -349K | 538K | 0 | 0 | -2.26M | 0 | 313K |
Cash from Investing | 9.28M | -87.2M | 10.8M | 32.48M | -53.25M | 58.35M | 38.77M | 25.34M | 167K | 155K |
Capital Expenditures | -2.58M | -5.65M | -1.25M | -395K | -679K | -728K | -214K | -14K | 0 | 0 |
CapEx % of Revenue | 105.48% | 224.37% | 56.25% | 72.48% | 38.71% | 61.69% | 6.35% | 175% | - | - |
Acquisitions | 40.43M | 0 | 0 | -28.52M | -1.27M | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 11K | -81.55M | 0 | 28.52M | 1.27M | 0 | 16K | 1.33M | 167K | 155K |
Cash from Financing | 66.68M | 82.48M | 79.6M | 13.39M | 89.38M | -2.04M | 20.94M | 172K | 0 | 0 |
Debt Issued (Net) | -408K | -427K | -266K | -208K | -8K | -13K | -13K | -4K | 0 | 0 |
Equity Issued (Net) | 67.08M | 82.67M | 57M | 13.54M | 89.09M | -2.23M | 20.83M | 22K | 0 | 0 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | -2.52M | 0 | 0 | 0 | 0 |
Other Financing | 5K | 244K | 22.87M | 58K | 301K | 198K | 125K | 154K | 0 | 0 |
Net Change in Cash | 44.9M▲ 0% | -47.19M▼ 205.1% | 14.93M▲ 131.6% | 6.32M▼ 57.7% | -16.07M▼ 354.1% | -577K▲ 96.4% | 8.1M▲ 1503.6% | -6.15M▼ 175.9% | -4.19M▲ 31.8% | -3.17M▲ 0% |
Free Cash Flow | -33.63M▲ 0% | -48.12M▼ 43.1% | -76.72M▼ 59.4% | -39.95M▲ 47.9% | -52.88M▼ 32.4% | -57.62M▼ 9.0% | -51.83M▲ 10.0% | -31.67M▲ 38.9% | -4.36M▲ 86.2% | -3.32M▲ 0% |
FCF Margin % | -1376.15% | -1909.68% | -3449.6% | -7329.91% | -3014.65% | -4882.71% | -1537.47% | -395900% | - | - |
FCF Growth % | -26.75% | -43.09% | -59.42% | 47.93% | -32.36% | -8.96% | 10.05% | 38.89% | 86.24% | 80.96% |
FCF per Share | -75.02 | -30.23 | -38.00 | -16.72 | -14.34 | -12.05 | -7.97 | -2.60 | -0.35 | -0.27 |
FCF Conversion (FCF/Net Income) | 0.77x | 0.88x | 1.47x | 0.67x | 0.86x | 0.86x | 0.90x | 1.36x | 4.34x | 5.18x |
Interest Paid | 0 | 0 | 21K | 0 | 0 | 2K | 1K | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 14K | 5K | 0 | 0 |
SYBX Key Ratios
Synlogic, Inc. (SYBX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -55.54% | -46.32% | -36.56% | -43.5% | -46.16% | -57.55% | -91.46% | -84.32% | -8.17% | -5.42% |
Return on Invested Capital (ROIC) | -139.56% | -68.47% | -30.33% | -34.73% | -35.49% | -42.41% | -67.26% | -205.7% | - | 98.71% |
Gross Margin | 100% | -491.15% | 100% | 100% | 100% | 100% | 100% | 100% | - | - |
Net Margin | -1652.09% | -1922.02% | -2309.94% | -10857.43% | -3452.74% | -5605.68% | -1699.26% | -291987.5% | - | - |
Debt / Equity | 0.01x | 0.00x | 0.16x | 0.20x | 0.14x | 0.25x | 0.40x | - | - | 0.00x |
Interest Coverage | -707.37x | -1125.40x | -2445.33x | -9861.17x | -30279.50x | -33072.50x | -57267.00x | - | - | - |
FCF Conversion | 0.77x | 0.88x | 1.47x | 0.67x | 0.86x | 0.86x | 0.90x | 1.36x | 4.34x | 5.18x |
Revenue Growth | 450.45% | 3.11% | -11.75% | -75.49% | 221.83% | -32.73% | 185.68% | -99.76% | -100% | - |
Related:SYBX Dividend History·SYBX Revenue History·SYBX Price History·SYBX P/E History·SYBX Financial Ratios·SYBX Institutional Holders
SYBX SEC Filings & Documents
Synlogic, Inc. (SYBX) SEC filings — annual & quarterly reports (10-K, 10-Q)
SYBX Frequently Asked Questions
Synlogic, Inc. (SYBX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Synlogic, Inc. (SYBX) saw revenue decline by 100.0% over the past year.
Synlogic, Inc. (SYBX) reported a net loss of $0.6M for fiscal year 2025.
Dividend & Returns
Synlogic, Inc. (SYBX) has a return on equity (ROE) of -8.2%. Negative ROE indicates the company is unprofitable.
Synlogic, Inc. (SYBX) had negative free cash flow of $3.3M in fiscal year 2025, likely due to heavy capital investments.